Literature DB >> 21944578

[Preimplantation diagnosis with HLA typing: birth of the first double hope child in France].

F Lamazou1, J Steffann, N Frydman, P Burlet, N Gigarel, S Romana, J-P Bonnefont, M Lelorch, L Hesters, R Fanchin, V Kerbrat, M Vekemans, A Munnich, R Frydman.   

Abstract

Preimplantation genetic diagnosis (PGD) is authorized in France since 1999. After 10 years, technical results are encouraging. With the development of new technologies, our team is able to diagnosis the large majority of chromosome translocations and 75 monogenic diseases. However, PGD remains limited because of the growing augmentation of demands causing an increasing delay for the first procedure of more than 18 months. Since 2006, 19 couples asked for a PGD with HLA typing. In January 2011, 11 couples have already been included in our PGD program. The birth of the first child after PGD with HLA typing offers new perspectives of treatment for these couples.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21944578     DOI: 10.1016/j.jgyn.2011.08.007

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  Experience of preimplantation genetic diagnosis with HLA matching at the University Hospital Virgen del Rocío in Spain: technical and clinical overview.

Authors:  Raquel María Fernández; Ana Peciña; Maria Dolores Lozano-Arana; Beatriz Sánchez; Jordi Guardiola; Juan Carlos García-Lozano; Salud Borrego; Guillermo Antiñolo
Journal:  Biomed Res Int       Date:  2014-04-24       Impact factor: 3.411

2.  A healthy HLA-matched baby born by using a combination of aCGH and Karyomapping: the first latin american case.

Authors:  Andrea Delgado; Guillermo Llerena; Rosmary Lopez; Jimmy Portella; Naomi Inoue; Luis Noriega-Hoces; Luis Guzman
Journal:  JBRA Assist Reprod       Date:  2017-12-01

3.  Novel one-step multiplex PCR-based method for HLA typing and preimplantational genetic diagnosis of β-Thalassemia.

Authors:  Raquel M Fernández; Ana Peciña; Maria Dolores Lozano-Arana; Juan Carlos García-Lozano; Salud Borrego; Guillermo Antiñolo
Journal:  Biomed Res Int       Date:  2013-04-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.